HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis

Objectives Lower high-density lipoprotein cholesterol (HDL-C) levels have been observed in chronic liver disease patients. The aim of this study was to develop a model that incorporates HDL-C levels and the Model for End-stage Liver Disease (MELD) score to predict 30-day mortality in Asian cirrhosis...

Full description

Bibliographic Details
Main Authors: Yue Wang, Wenjuan Shen, Fang Huang, Chenyan Yu, Liting Xi, Jingwen Gao, Minyue Yin, Xiaolin Liu, Jiaxi Lin, Lu Liu, Huixian Zhang, Jinzhou Zhu, Yu Hong
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605221109385
_version_ 1828542686055890944
author Yue Wang
Wenjuan Shen
Fang Huang
Chenyan Yu
Liting Xi
Jingwen Gao
Minyue Yin
Xiaolin Liu
Jiaxi Lin
Lu Liu
Huixian Zhang
Jinzhou Zhu
Yu Hong
author_facet Yue Wang
Wenjuan Shen
Fang Huang
Chenyan Yu
Liting Xi
Jingwen Gao
Minyue Yin
Xiaolin Liu
Jiaxi Lin
Lu Liu
Huixian Zhang
Jinzhou Zhu
Yu Hong
author_sort Yue Wang
collection DOAJ
description Objectives Lower high-density lipoprotein cholesterol (HDL-C) levels have been observed in chronic liver disease patients. The aim of this study was to develop a model that incorporates HDL-C levels and the Model for End-stage Liver Disease (MELD) score to predict 30-day mortality in Asian cirrhosis patients. Methods Cirrhosis patients were recruited from two hospitals in this retrospective observational study. Propensity score matching was used. The model’s performance was evaluated, including its ability to predict 30-day mortality, accuracy, and clinical utility. Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated. Results The HDL-C + MELD model showed good ability to predict 30-day mortality (area under the curve, 0.784; sensitivity, 0.797; specificity, 0.632), which was better than that of the MELD score alone. It also showed good calibration and a net benefit for all patients, which was better than that of the MELD score, except at the threshold probability. NRI and IDI results confirmed that adding HDL-C levels to the MELD score improved the model’s performance in predicting 30-day mortality. Conclusion We added HDL-C levels to the MELD score to predict 30-day mortality in Asian patients with cirrhosis. The HDLC + MELD model shows good ability to predict 30-day mortality and clinical utility.
first_indexed 2024-12-12T02:01:28Z
format Article
id doaj.art-0d836f641ed04ed2b232a6020d106c14
institution Directory Open Access Journal
issn 1473-2300
language English
last_indexed 2024-12-12T02:01:28Z
publishDate 2022-07-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-0d836f641ed04ed2b232a6020d106c142022-12-22T00:42:10ZengSAGE PublishingJournal of International Medical Research1473-23002022-07-015010.1177/03000605221109385HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosisYue WangWenjuan ShenFang HuangChenyan YuLiting XiJingwen GaoMinyue YinXiaolin LiuJiaxi LinLu LiuHuixian ZhangJinzhou ZhuYu HongObjectives Lower high-density lipoprotein cholesterol (HDL-C) levels have been observed in chronic liver disease patients. The aim of this study was to develop a model that incorporates HDL-C levels and the Model for End-stage Liver Disease (MELD) score to predict 30-day mortality in Asian cirrhosis patients. Methods Cirrhosis patients were recruited from two hospitals in this retrospective observational study. Propensity score matching was used. The model’s performance was evaluated, including its ability to predict 30-day mortality, accuracy, and clinical utility. Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) were calculated. Results The HDL-C + MELD model showed good ability to predict 30-day mortality (area under the curve, 0.784; sensitivity, 0.797; specificity, 0.632), which was better than that of the MELD score alone. It also showed good calibration and a net benefit for all patients, which was better than that of the MELD score, except at the threshold probability. NRI and IDI results confirmed that adding HDL-C levels to the MELD score improved the model’s performance in predicting 30-day mortality. Conclusion We added HDL-C levels to the MELD score to predict 30-day mortality in Asian patients with cirrhosis. The HDLC + MELD model shows good ability to predict 30-day mortality and clinical utility.https://doi.org/10.1177/03000605221109385
spellingShingle Yue Wang
Wenjuan Shen
Fang Huang
Chenyan Yu
Liting Xi
Jingwen Gao
Minyue Yin
Xiaolin Liu
Jiaxi Lin
Lu Liu
Huixian Zhang
Jinzhou Zhu
Yu Hong
HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis
Journal of International Medical Research
title HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis
title_full HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis
title_fullStr HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis
title_full_unstemmed HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis
title_short HDL-C levels added to the MELD score improves 30-day mortality prediction in Asian patients with cirrhosis
title_sort hdl c levels added to the meld score improves 30 day mortality prediction in asian patients with cirrhosis
url https://doi.org/10.1177/03000605221109385
work_keys_str_mv AT yuewang hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT wenjuanshen hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT fanghuang hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT chenyanyu hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT litingxi hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT jingwengao hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT minyueyin hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT xiaolinliu hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT jiaxilin hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT luliu hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT huixianzhang hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT jinzhouzhu hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis
AT yuhong hdlclevelsaddedtothemeldscoreimproves30daymortalitypredictioninasianpatientswithcirrhosis